DD82733A - - Google Patents

Info

Publication number
DD82733A
DD82733A DD82733DA DD82733A DD 82733 A DD82733 A DD 82733A DD 82733D A DD82733D A DD 82733DA DD 82733 A DD82733 A DD 82733A
Authority
DD
German Democratic Republic
Application number
Publication of DD82733A publication Critical patent/DD82733A/xx

Links

DD82733D DD82733A (fr)

Publications (1)

Publication Number Publication Date
DD82733A true DD82733A (fr)

Family

ID=268662

Family Applications (1)

Application Number Title Priority Date Filing Date
DD82733D DD82733A (fr)

Country Status (1)

Country Link
DD (1) DD82733A (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009018152A1 (fr) * 2007-07-27 2009-02-05 Aton Pharma, Inc. Utilisations de trientine et de pénicillamine en tant que contre-mesures d'une contamination métallique

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009018152A1 (fr) * 2007-07-27 2009-02-05 Aton Pharma, Inc. Utilisations de trientine et de pénicillamine en tant que contre-mesures d'une contamination métallique

Similar Documents

Publication Publication Date Title
US5500126A (en) Process for removal of metal ions from aqueous solutions
US10322100B2 (en) Maternal chelation for embryo, fetal and infant benefit
US5494935A (en) Methods for oral decorporation of metals
CN101820870B (zh) 曲恩汀和青霉胺作为金属污染对抗物的用途
EP2542547B1 (fr) Composés, compositions et leur utilisation dans le traîtement de maladies liées à la retention du cuivre ou ou désordres hépatiques
US10874624B2 (en) Stable trientine formulations
US8911705B2 (en) Diagnostic substance and method for the analysis of metabolism processes in the brain
DD82733A (fr)